亚洲妇科肿瘤学会（ASGO）2024年年会在印度尼西亚巴厘岛举行。 - Suppr | 超能文献

文献检索
文档翻译
深度研究
学术资讯

Zotero 插件

邀请有礼
套餐&价格
历史记录

应用&插件

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

定价

高级版会员购买积分包购买API积分包

服务

文献检索文档翻译深度研究 API 文档 MCP 服务

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Asian Society of Gynecologic Oncology (ASGO) 2024 Annual Meeting in Bali, Indonesia.

作者信息

Anggraeni Tricia Dewi, Tjokroprawiro Brahmana Askandar, Kim Jae-Weon, Park Jeong-Yeol

机构信息

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Dr. Cipto Mangunkusumo National General Hospital and Universitas Indonesia, Jakarta, Indonesia.

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Dr. Soetomo General Academic Hospital and Universitas Airlangga, Surabaya, Indonesia.

出版信息

J Gynecol Oncol. 2025 Mar;36(2):e97. doi: 10.3802/jgo.2025.36.e97. Epub 2025 Mar 10.

DOI:10.3802/jgo.2025.36.e97

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11964969/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35a0/11964969/c09c3d989071/jgo-36-e97-g012.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35a0/11964969/e23d71ff3e85/jgo-36-e97-g001.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35a0/11964969/6e81d30562ee/jgo-36-e97-g002.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35a0/11964969/6141d4d16bbb/jgo-36-e97-g003.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35a0/11964969/73321b10d3ac/jgo-36-e97-g004.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35a0/11964969/5171254874ae/jgo-36-e97-g005.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35a0/11964969/b945dd35b41f/jgo-36-e97-g006.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35a0/11964969/576997cde84d/jgo-36-e97-g007.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35a0/11964969/473933eaced8/jgo-36-e97-g008.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35a0/11964969/d4cd519debdf/jgo-36-e97-g009.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35a0/11964969/06a940d3425a/jgo-36-e97-g010.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35a0/11964969/4c13595dc7b7/jgo-36-e97-g011.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35a0/11964969/c09c3d989071/jgo-36-e97-g012.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35a0/11964969/e23d71ff3e85/jgo-36-e97-g001.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35a0/11964969/6e81d30562ee/jgo-36-e97-g002.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35a0/11964969/6141d4d16bbb/jgo-36-e97-g003.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35a0/11964969/73321b10d3ac/jgo-36-e97-g004.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35a0/11964969/5171254874ae/jgo-36-e97-g005.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35a0/11964969/b945dd35b41f/jgo-36-e97-g006.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35a0/11964969/576997cde84d/jgo-36-e97-g007.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35a0/11964969/473933eaced8/jgo-36-e97-g008.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35a0/11964969/d4cd519debdf/jgo-36-e97-g009.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35a0/11964969/06a940d3425a/jgo-36-e97-g010.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35a0/11964969/4c13595dc7b7/jgo-36-e97-g011.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35a0/11964969/c09c3d989071/jgo-36-e97-g012.jpg

相似文献

1

Asian Society of Gynecologic Oncology (ASGO) 2024 Annual Meeting in Bali, Indonesia.亚洲妇科肿瘤学会（ASGO）2024年年会在印度尼西亚巴厘岛举行。

J Gynecol Oncol. 2025 Mar;36(2):e97. doi: 10.3802/jgo.2025.36.e97. Epub 2025 Mar 10.

2

Second Biennial Meeting of Asian Society of Gynecologic Oncology (ASGO): a turning point from good old days to a better future.亚洲妇科肿瘤学会（ASGO）第二届双年会议：从往昔美好岁月迈向更美好未来的转折点。

Gynecol Oncol. 2012 Jun;125(3):518-9. doi: 10.1016/j.ygyno.2012.02.012. Epub 2012 Feb 23.

3

Asian Society of Gynecologic Oncology (ASGO): a central platform against gynecologic cancers in Asia.亚洲妇科肿瘤学会（ASGO）：亚洲对抗妇科癌症的核心平台。

J Gynecol Oncol. 2009 Jun;20(2):65-6. doi: 10.3802/jgo.2009.20.2.65. Epub 2009 Jun 29.

4

When Impact Multiplies: Defining Trials and Insights from the 2025 Society of Gynecologic Oncology Annual Meeting.当影响力成倍增长：定义试验及来自2025年妇科肿瘤学会年会的见解

Int J Gynecol Cancer. 2025 Jul;35(7):101895. doi: 10.1016/j.ijgc.2025.101895. Epub 2025 Apr 22.

5

Asian Society of Gynecologic Oncology (ASGO): A new society for doctors working against gynecologic cancers in Asia.亚洲妇科肿瘤学会（ASGO）：一个面向在亚洲抗击妇科癌症的医生的新学会。

Gynecol Oncol. 2009 Mar;112(3):442-3. doi: 10.1016/j.ygyno.2009.01.010.

6

Prevalence and risk factors of high-risk HPV and cervical abnormalities in HIV-positive women in Bali, Indonesia.印度尼西亚巴厘岛HIV阳性女性高危型人乳头瘤病毒（HPV）感染及宫颈病变的患病率和危险因素

BMC Infect Dis. 2025 Mar 28;25(1):432. doi: 10.1186/s12879-025-10827-4.

7

Determinants of Vaccination Coverage and Consequences for Rabies Control in Bali, Indonesia.印度尼西亚巴厘岛狂犬病疫苗接种覆盖率的决定因素及其对狂犬病防控的影响

Front Vet Sci. 2017 Jan 9;3:123. doi: 10.3389/fvets.2016.00123. eCollection 2016.

8

Asian society of gynecologic oncology workshop 2010.亚洲妇科肿瘤学会 2010 年研讨会。

J Gynecol Oncol. 2010 Sep;21(3):137-50. doi: 10.3802/jgo.2010.21.3.137. Epub 2010 Sep 28.

9

Gynecologic oncology training systems in Europe: a report from the European network of young gynaecological oncologists.欧洲妇科肿瘤学培训系统：来自欧洲青年妇科肿瘤学家网络的报告。

Int J Gynecol Cancer. 2011 Nov;21(8):1500-6. doi: 10.1097/IGC.0b013e3182202d17.

10

Sister Society Meeting on Global Education Development and Collaboration: Meeting Report.全球教育发展与合作姐妹协会会议：会议报告

Int J Gynecol Cancer. 2016 Jul;26(6):1186-8. doi: 10.1097/IGC.0000000000000735.

本文引用的文献

1

Real-world evidence of Trastuzumab Deruxtecan (T-DXd) Efficacy in HER2-expressing gynecological malignancies.曲妥珠单抗德鲁昔单抗（T-DXd）治疗HER2表达的妇科恶性肿瘤的真实世界疗效证据。

BMC Cancer. 2024 Dec 5;24(1):1503. doi: 10.1186/s12885-024-13226-1.

2

Lymph node assessment in cervical cancer: current approaches.宫颈癌的淋巴结评估：当前方法

Front Oncol. 2024 Nov 11;14:1435532. doi: 10.3389/fonc.2024.1435532. eCollection 2024.

3

Efficacy and safety of immune checkpoint inhibitors for advanced or recurrent endometrial cancer: a systematic review and network meta-analysis.

免疫检查点抑制剂治疗晚期或复发性子宫内膜癌的疗效和安全性：系统评价和网络荟萃分析。

BMC Cancer. 2024 Oct 21;24(1):1298. doi: 10.1186/s12885-024-13058-z.

4

ESGO/EURACAN/GCIG guidelines for the management of patients with uterine sarcomas.ESGO/EURACAN/GCIG子宫肉瘤患者管理指南

Int J Gynecol Cancer. 2024 Oct 7;34(10):1499-1521. doi: 10.1136/ijgc-2024-005823.

5

Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial.阿替利珠单抗联合化疗治疗晚期或复发性子宫内膜癌（AtTEnd）：一项随机、双盲、安慰剂对照、III 期临床试验。

Lancet Oncol. 2024 Sep;25(9):1135-1146. doi: 10.1016/S1470-2045(24)00334-6. Epub 2024 Aug 2.

6

Efficacy and safety of nivolumab monotherapy in patients with unresectable clear cell sarcoma and alveolar soft part sarcoma (OSCAR Trial/NCCH1510).尼伏鲁单抗单药治疗不可切除的透明细胞肉瘤和肺泡软组织肉瘤患者的疗效和安全性（OSCAR 试验/NCCH1510）。

Cancer. 2024 Nov 15;130(22):3836-3844. doi: 10.1002/cncr.35483. Epub 2024 Jul 30.

7

Immunotherapy for endometrial cancer.子宫内膜癌的免疫疗法。

Int J Clin Oncol. 2025 Mar;30(3):449-456. doi: 10.1007/s10147-024-02568-2. Epub 2024 Jun 24.

8

Progress in the study of antibody-drug conjugates for the treatment of cervical cancer.用于治疗宫颈癌的抗体-药物偶联物的研究进展

Front Oncol. 2024 Jun 6;14:1395784. doi: 10.3389/fonc.2024.1395784. eCollection 2024.

9

Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial.在 ENGOT-EN6/GOG-3031/RUBY 试验中，接受 dostarlimab 联合卡铂-紫杉醇治疗的子宫内膜癌患者的总生存期。

Ann Oncol. 2024 Aug;35(8):728-738. doi: 10.1016/j.annonc.2024.05.546. Epub 2024 Jun 10.

10

Antibody-Drug Conjugates: A promising breakthrough in cancer therapy.抗体药物偶联物：癌症治疗的突破性进展。

Int J Pharm. 2024 Jun 25;659:124211. doi: 10.1016/j.ijpharm.2024.124211. Epub 2024 Jun 1.